The shelf registration is now effective, meaning Eupraxia can sell shares at any time. Traders should watch for a prospectus supplement (424B5) that would reveal the actual offering size and terms, which would crystallize the dilution risk. The 91% bullish analyst consensus may be tested if a dilutive offering materializes.
Price Chart
Executive Summary
Eupraxia Pharmaceuticals' SEC registration statement (File No. 333-298036) became effective on August 24, 2026. The filing is an F-10 registration, indicating a Canadian issuer shelf offering. This allows the company to sell securities at any time, creating potential dilution overhang for existing common shareholders. No specific offering size or pricing details are disclosed in the filing documents.
Key Facts
- EFFECT notice for File No. 333-298036, an F-10 registration (Canadian issuer shelf).
- Effectiveness date: August 24, 2026.
- No offering size, pricing, or specific securities type disclosed in the filing documents.
- The shelf registration creates a standing dilution overhang for EPRX common stock.
- Company is a pharmaceutical preparations firm with a $444M market cap and 91% analyst bullish consensus.
Financial Impact
Undisclosed offering size; shelf registration creates potential dilution overhang for common equity.
Risk Factors
- Potential dilutive secondary offering at any time under the effective shelf.
- No specific use-of-proceeds or offering size disclosed, creating uncertainty.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002742 |
| Document: 9999999995-26-002742-index.html | 9999999995-26-002742 |
| Document: 9999999995-26-002742.txt | 9999999995-26-002742 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 6-K | $7.59 | awaiting T+5 | — | $6.85 (−9.75%) |
Oct 15, 2026 11d ago | 6-K | $6.77 $7.59 | ▲ +12.11% | ▲ +13.13% | $6.85 (+1.18%) |
Oct 9, 2026 17d ago | 6-K | $7.46 $6.62 | ▼ −11.26% | ▼ −9.29% | $6.85 (−8.18%) |
Sep 30, 2026 26d ago | 6-K | $9.10 $7.78 | ▼ −14.51% | ▼ −16.42% | $6.85 (−24.73%) |
Sep 30, 2026 26d ago | Press Release | $9.10 $7.78 | ▼ −14.51% | ▼ −16.42% | $6.85 (−24.73%) |
Aug 25, 2026 9w ago | EFFECT | $7.42 $6.34 | ▲ +14.56% | ▲ +14.02% | $6.85 (+7.68%) |
Aug 13, 2026 10w ago | 6-K | $6.67 $6.76 | ▲ +1.35% | ▲ +3.31% | $6.85 (+2.70%) |
Aug 11, 2026 10w ago | Press Release | $6.48 $7.01 | ▲ +8.18% | ▲ +8.62% | $6.85 (+5.71%) |
Jul 15, 2026 14w ago | 6-K | $6.52 $6.42 | ▼ −1.53% | ▼ −0.55% | $6.85 (+5.06%) |
Jun 19, 2026 18w ago | Press Release | $6.64 $6.60 | ▼ −0.60% | ▲ +1.47% | $6.85 (+3.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers